TP53 and cancer: We assessed the apoptotic capabilities of p53-R9 in human cancer cells due to an incomplete elephant genome assembly, a lack of immortalized elephant cell lines, and issues with cross-species specificity of antibodies that were developed to recognize human or mouse proteins.